» Articles » PMID: 8774539

The D2 Dopamine Receptor Gene As a Determinant of Reward Deficiency Syndrome

Overview
Journal J R Soc Med
Specialty General Medicine
Date 1996 Jul 1
PMID 8774539
Citations 175
Authors
Affiliations
Soon will be listed here.
Abstract

The dopaminergic system, and in particular the dopamine D2 receptor, has been profoundly implicated in reward mechanisms in the brain. Dysfunction of the D2 dopamine receptors leads to aberrant substance seeking behaviour (alcohol, drug, tobacco, and food) and other related behaviours (pathological gambling, Tourette's syndrome, and attention deficit hyperactivity disorder). We propose that variants of the D2 dopamine receptor gene are important common genetic determinants of the 'reward deficiency syndrome'.

Citing Articles

Association between the Taq1A polymorphism and problematic media use in preadolescent children.

Emond J, Renier T, Yeum D, Carlson D, Ballarino G, Gilbert-Diamond D Front Psychol. 2025; 15:1395957.

PMID: 39845554 PMC: 11752389. DOI: 10.3389/fpsyg.2024.1395957.


Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration Therapy.

Zeine F, Jafari N, Baron D, Bowirrat A, Pinhasov A, Norling B J Addict Psychiatry. 2024; 8(1):50-95.

PMID: 39635461 PMC: 11615735.


Cannabidiol Plays a Modulatory Function on the Methamphetamine-Induced Reward Through Hippocampal D2-Like Dopamine Receptors.

Mohammadi M, Omidiani S, Azizbeigi R, Haghparast A Neurochem Res. 2024; 50(1):6.

PMID: 39540967 DOI: 10.1007/s11064-024-04256-z.


Dopamine in Sports: A Narrative Review on the Genetic and Epigenetic Factors Shaping Personality and Athletic Performance.

Huminska-Lisowska K Int J Mol Sci. 2024; 25(21).

PMID: 39519153 PMC: 11546834. DOI: 10.3390/ijms252111602.


The First Pilot Epigenetic Type Improvement of Neuropsychiatric Symptoms in a Polymorphic Dopamine D2 (-DRD2/ANKK (Taq1A)), OPRM1 (A/G), DRD3 (C/T), and MAOA (4R) Compromised Preadolescence Male with Putative PANDAS/CANS: Positive Clinical Outcome....

Blum K, Elman I, Han D, Hanna C, Baron D, Gupta A Open J Immunol. 2024; 14(3):60-86.

PMID: 39507617 PMC: 11539193. DOI: 10.4236/oji.2024.143006.


References
1.
Bolos A, Dean M, Ramsburg M, Brown G, Goldman D . Population and pedigree studies reveal a lack of association between the dopamine D2 receptor gene and alcoholism. JAMA. 1990; 264(24):3156-60. View

2.
Comings D, Ferry L, Burchette R, Chiu C, Muhleman D . The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. Pharmacogenetics. 1996; 6(1):73-9. DOI: 10.1097/00008571-199602000-00006. View

3.
Noble E, Blum K, Ritchie T, Montgomery A, Sheridan P . Allelic association of the D2 dopamine receptor gene with receptor-binding characteristics in alcoholism. Arch Gen Psychiatry. 1991; 48(7):648-54. DOI: 10.1001/archpsyc.1991.01810310066012. View

4.
Parsian A, Todd R, Devor E, OMalley K, Suarez B, Reich T . Alcoholism and alleles of the human D2 dopamine receptor locus. Studies of association and linkage. Arch Gen Psychiatry. 1991; 48(7):655-63. DOI: 10.1001/archpsyc.1991.01810310073013. View

5.
Sarkar G, Sommer S . Haplotyping by double PCR amplification of specific alleles. Biotechniques. 1991; 10(4):436, 438, 440. View